For every line, there’s a starting point. Each story has a writer, and behind every success, there’s a bright idea, a well-organized plan, and a team of believers. dHealth’s president saw a solution and started writing the company’s story in 2017, with a crucial vision of using DLT, distributed legendary technology, to alleviate some of the major pain points faced in the healthcare industry today.
Let’s introduce you, our dear readers, to dHealth’s storyline, how it started, and how we got here today.
A background insight
dHealth got initially incorporated in November 2017 as HIT foundation. Since then, we’ve engaged with various entities, corporations, and Pharma companies to build their use cases on our blockchain. The initial use cases that we developed were under the HIT foundation.
In 2019, we built a project with the National Lung Hospital in Vietnam, primarily for data collection and decentralizing this data to give back its ownership and incentives to patients. It was a mobile application to capture data, built with the Symbol protocol.
In 2020, dHealth worked with Novartis and Roche and started another project with Swiss TPH. The end of 2020 was a turning point for the foundation, where they had established a new platform strategy and rebranded HIT foundation to dHealth Foundation.
As we desire to focus entirely on healthcare use cases, dHealth decided in 2021 to branch off into creating a genuinely health-centric blockchain protocol while still maintaining the legitimacy and the full support and stability of the initial founding blocks of the network.
So in 2021, dHealth closed a certain amount of funding from a pool of different sources, one of which was the NEM Foundation. Others were Darkpool Ventures and AU21 Capital.
In March 2021, the actual mainnet, the dHealth network, went live. Gregory Saive, CTO at dHealth, was a significant pioneer in creating a unique network with all the integration possibilities and the simplicity of querying the network and writing data on it.
Since the mainnet has gone live, we’ve engaged with various institutional partners and partners looking to build engaging use cases on the network. The first one that joined was a blockchain Center at the University of Zurich in May 2021. Following it were pharmaceutical giants that we still work with today, like Novartis, Roche, and Eli Lilly.
A highlight of August 2021 was our engagement with OrganX, affiliated with Paris transplant Group. This entity exists to further the research and application of technology to organ transfer, along with different use cases. One of the significant discussions in the process of being executed is the whole digital organ exchange using blockchain and AI, which is a project of potential in the upcoming months.
In December 2021, Eli Lilly, one of the top pharmaceutical companies worldwide, joined dHealth as a node partner.
In April 2022, Bowhead Health joined as a supernode partner, a Canadian company centered around gamifying the capture of health data from patients.
In June 2022, dHealth reached its first halving as a network. Then, we went live on MEXC with our native token, with all early holders of dHealth being part of that milestone event.
dHealth started its journey with the idea of not being a one-time project. It has a crucial mission of constantly innovating to benefit people and improve the plagued healthcare system. dHealth is currently building a toolkit of components and SDKs to empower developers. It is also collaborating with Roche to develop DiMi, a digital twin for users’ identity, and it’s upgrading HealthToEarn to Elevate. Stay tuned to the other projects coming up next on dHealth’s roadmap, like a signer app, self-sovereign storage for health data (3SHD), a stablecoin release, and many use cases with high potential.